[HTML][HTML] Small molecule inhibitors of CXCR4

B Debnath, S Xu, F Grande, A Garofalo, N Neamati - Theranostics, 2013 - ncbi.nlm.nih.gov
CXCR4 is a G-protein-coupled receptor involved in a number of physiological processes in
the hematopoietic and immune systems. The SDF-1/CXCR4 axis is significantly associated …

Chloroquine cardiomyopathy–a review of the literature

E Tönnesmann, R Kandolf… - Immunopharmacology and …, 2013 - Taylor & Francis
Chloroquine and hydroxychloroquine are still used for the prevention and treatment of
malaria. Moreover, they are experiencing a renaissance in the long-term therapy of …

Chloroquine prevents progression of experimental pulmonary hypertension via inhibition of autophagy and lysosomal bone morphogenetic protein type II receptor …

L Long, X Yang, M Southwood, J Lu… - Circulation …, 2013 - Am Heart Assoc
Rationale: Pulmonary arterial hypertension (PAH) is characterized by excessive proliferation
and apoptosis resistance in pulmonary artery smooth muscle cells (PASMCs). Objective: We …

[HTML][HTML] Hydroxychloroquine decreases Th17-related cytokines in systemic lupus erythematosus and rheumatoid arthritis patients

JC Silva, HA Mariz, LF Rocha, PSS Oliveira, AT Dantas… - Clinics, 2013 - SciELO Brasil
OBJECTIVES: Hydroxychloroquine is an antimalarial agent that has been used in systemic
lupus erythematosus and rheumatoid arthritis treatment for many years. Recently, novel …

Chloroquine: modes of action of an undervalued drug

R Thomé, SCP Lopes, FTM Costa, L Verinaud - Immunology letters, 2013 - Elsevier
For more than two decades, chloroquine (CQ) was largely and deliberately used as first
choice drug for malaria treatment. However, worldwide increasing cases of resistant strains …

[HTML][HTML] Modulation of neutrophil NETosis: interplay between infectious agents and underlying host physiology

S Hahn, S Giaglis, CS Chowdury, I Hösli… - Seminars in …, 2013 - Springer
The ability of neutrophils and other leucocyte members of the innate immune system to
expel their DNA into the extracellular environment in a controlled manner in order to trap …

Design, synthesis and biological evaluation of novel antagonist compounds of Toll-like receptors 7, 8 and 9

ER Kandimalla, L Bhagat, D Wang, D Yu… - Nucleic acids …, 2013 - academic.oup.com
Oligonucleotides containing an immune-stimulatory motif and an immune-regulatory motif
act as antagonists of Toll-like receptor (TLR) 7 and TLR9. In the present study, we designed …

The lysosomal inhibitor, chloroquine, increases cell surface BMPR-II levels and restores BMP9 signalling in endothelial cells harbouring BMPR-II mutations

BJ Dunmore, KM Drake, PD Upton… - Human Molecular …, 2013 - academic.oup.com
Pulmonary arterial hypertension (PAH) is characterized by dysregulated pulmonary artery
endothelial cell (PAEC) proliferation, apoptosis and permeability. Loss-of-function mutations …

Hydroxychloroquine niosomes: a new trend in topical management of oral lichen planus

ER Bendas, H Abdullah, MHM El-Komy… - International journal of …, 2013 - Elsevier
The work aimed at studying a novel topical niosomal gel formulation of hydroxychloroquine
for the management of oral lichen planus. Niosomes have been reported as conceivable …

[HTML][HTML] Serious Non-AIDS events: Immunopathogenesis and interventional strategies

DC Hsu, I Sereti, J Ananworanich - AIDS Research and Therapy, 2013 - Springer
Despite the major advances in the management of HIV infection, HIV-infected patients still
have greater morbidity and mortality than the general population. Serious non-AIDS events …